ArthriComplex Topical Roll On
Natural health product licensed in Canada
- Licence holder
- Holista Health (Canada) Inc.
- NPN or DIN-HM
- 80004222
- Status
- Inactive licence
- Licence date
- 5 October 2007
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Capsaïcine | 0.025 % |
Non-medicinal ingredients
Butylcarbamate d'iodopropynyle, Juniperus communis, propylèneglycol, Eau purifiée, Betula lenta, triéthanolamine, Abies balsamea, Larrea tridentata, diazolidinyl urée, Achillea millefolium, Diethanolamine, Carbomère
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 0.025 % | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For temporary relief of aches and pains of muscles and joints associated with arthritic pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Avoid contact with eyes, mucous membrane, irritated or broken skin and wounds. Do not cover or bandage tightly. If rash or irritation occurs, discontinue use. If conditions worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use and consult a physician. The application of external heat (e.g. electric heating pad) may result in excessive skin irritation or skin burn.
- Contre-indications
Do not use if pregnant or breastfeeding.
Source
Official Health Canada record, licence 80004222
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.